Literature DB >> 20002558

Hepatitis C/HIV co-infection is associated with higher mortality in hospitalized patients with hepatitis C or HIV.

A N Ananthakrishnan1, E L McGinley, J Fangman, K Saeian.   

Abstract

Up to 10% of all patients with Hepatitis C virus (HCV) infection are co-infected with human immunodeficiency virus (HIV); 25-30% of HIV patients are co-infected with HCV. The aim of this study was to examine the association of HCV/HIV co-infection with outcomes of hospitalized patients compared to those with HCV or HIV monoinfection. Using the 2006 Nationwide Inpatient Sample, patients with HCV or HIV monoinfection or HCV/HIV co-infection were identified using ICD-9-CM codes. We compared liver-related and infection-related admission between the three groups of patients. Multivariate logistic regression was performed to identify independent predictors of in-hospital mortality. A total of 474,843 discharges with HCV monoinfection, 206,758 with HIV monoinfection and 56,304 with HCV/HIV co-infection were included. Liver-related admissions were more common in co-infected patients (15.4%) compared to those with HIV monoinfection (3.3%, P < 0.001). Primary infectious hospitalizations were more common in HIV monoinfection (33.9%) compared to co-infected patients (26%, P < 0.001). HCV/HIV co-infection was associated with higher mortality compared to HCV monoinfection (OR 1.41, 95% CI 1.20-1.65) but not when compared to monoinfected-HIV patients. HCV-associated cirrhosis or complications thereof conferred four times greater mortality risk in patients with HIV (OR 3.96, 95% CI 3.29-4.79). The rate of hospitalization for HCV/HIV co-infected patients (23.5%) was significantly higher than those with HCV (14.8%) or HIV (19.9%) (P < 0.001). HCV/HIV co-infection is associated with significantly higher rates of hospitalization and is a risk factor for in-hospital mortality compared to patients with isolated HCV.
© 2009 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20002558     DOI: 10.1111/j.1365-2893.2009.01232.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  9 in total

1.  Non-initiation of hepatitis C virus antiviral therapy in patients with human immunodeficiency virus/hepatitis C virus co-infection.

Authors:  Christine U Oramasionwu; Angela Dm Kashuba; Sonia Napravnik; David A Wohl; Lu Mao; Adaora A Adimora
Journal:  World J Hepatol       Date:  2016-03-08

Review 2.  Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation.

Authors:  Stephen E Congly; Karen E Doucette; Carla S Coffin
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

3.  HBV/HIV coinfection is associated with poorer outcomes in hospitalized patients with HBV or HIV.

Authors:  R Rajbhandari; T Jun; H Khalili; R T Chung; A N Ananthakrishnan
Journal:  J Viral Hepat       Date:  2016-06-13       Impact factor: 3.728

4.  Genetic Variability of Hepatitis C Virus (HCV) 5' Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin.

Authors:  Iwona Bukowska-Ośko; Agnieszka Pawełczyk; Karol Perlejewski; Natalia Kubisa; Kamila Caraballo Cortés; Magdalena Rosińska; Rafał Płoski; Maria Fic; Justyna Kaźmierczak; Marta Popiel; Piotr Ząbek; Andrzej Horban; Marek Radkowski; Tomasz Laskus
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

5.  Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study.

Authors:  Terence L Johnson; Joshua C Toliver; Lu Mao; Christine U Oramasionwu
Journal:  BMC Infect Dis       Date:  2014-04-23       Impact factor: 3.090

Review 6.  Hepatitis C virus: A critical approach to who really needs treatment.

Authors:  Elias Kouroumalis; Argyro Voumvouraki
Journal:  World J Hepatol       Date:  2022-01-27

7.  National trends in hospitalization and mortality rates for patients with HIV, HCV, or HIV/HCV coinfection from 1996-2010 in the United States: a cross-sectional study.

Authors:  Christine U Oramasionwu; Joshua C Toliver; Terence L Johnson; Heather N Moore; Christopher R Frei
Journal:  BMC Infect Dis       Date:  2014-10-10       Impact factor: 3.090

8.  Necrotizing Fasciitis Among Patients With Liver Cirrhosis in Texas, 2001 - 2010: A Population-Based Cohort Study.

Authors:  Lavi Oud; Phillip Watkins
Journal:  J Clin Med Res       Date:  2015-12-28

9.  Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis.

Authors:  Adeyinka Charles Adejumo; Oluwole Muyiwa Adegbala; Kelechi Lauretta Adejumo; Terence Ndonyi Bukong
Journal:  Can J Gastroenterol Hepatol       Date:  2018-09-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.